Novel Basic Isoflavones as Inhibitors of Bone Resorption
✍ Scribed by Maurizio Delcanale; Gabriele Amari; Elisabetta Armani; Milco Lipreri; Maurizio Civelli; Elisabetta Galbiati; Massimo Giossi; Paola Lorenza Caruso; Patrizia Crivori; Pierre-Alain Carrupt; Bernard Testa
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- German
- Weight
- 137 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0018-019X
No coin nor oath required. For personal study only.
✦ Synopsis
A number of aminoalkoxy analogues of ipriflavone ( 7-(1-methylethoxy)isoflavone) were prepared and examined for their capacity to inhibit bone resorption induced by bovine parathyroid hormone fragment 1 ± 34. Good-to-high activities were found for 7-(aminoalkoxy)isoflavone analogues. Their activity was influenced by a number of structural features, among which the length of the basic side chain, the basicity of the amino group, and the nature and position of substituents on the 3-phenyl ring. 4'-(Aminoalkoxy)ipriflavone derivatives were less active.
📜 SIMILAR VOLUMES
The eects of several novel monosaccharides upon thymidine incorporation into both normal and tumour cells were investigated. The monosaccharide 2-deoxy-3-[1-(R)-(ethoxycarbonyl)ethyl]-a-D-allo-pyranose had the most inhibitory eect on proliferation, with the (S)-enantiomer having less inhibitory eect
## Abstract Internal remodelling of bone occurs continually during life in discrete foci throughout cortex and large trabeculae. It is defined as the process of replacement of primaryappositional bone with Haversian bone occurring within the periosteal‐endosteal envelope. The foci are produced by o
Elevated levels of parathyroid hormone-related protein (PTHrP) in hypercalcemic myeloma patients were demonstrated in recent reports, suggesting that PTHrP behaves as a humoral mediator of hypercalcemia in myeloma. Herein we describe a hypercalcemic myeloma patient with a high serum PTHrP level. Mor